1. Home
  2. THRD vs MRAM Comparison

THRD vs MRAM Comparison

Compare THRD & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • MRAM
  • Stock Information
  • Founded
  • THRD 2019
  • MRAM 2008
  • Country
  • THRD United States
  • MRAM United States
  • Employees
  • THRD N/A
  • MRAM N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • MRAM Semiconductors
  • Sector
  • THRD Health Care
  • MRAM Technology
  • Exchange
  • THRD Nasdaq
  • MRAM Nasdaq
  • Market Cap
  • THRD 157.7M
  • MRAM 130.3M
  • IPO Year
  • THRD 2022
  • MRAM 2016
  • Fundamental
  • Price
  • THRD $3.55
  • MRAM $5.07
  • Analyst Decision
  • THRD Hold
  • MRAM Strong Buy
  • Analyst Count
  • THRD 3
  • MRAM 2
  • Target Price
  • THRD $5.00
  • MRAM $9.00
  • AVG Volume (30 Days)
  • THRD 343.0K
  • MRAM 95.7K
  • Earning Date
  • THRD 05-14-2025
  • MRAM 04-30-2025
  • Dividend Yield
  • THRD N/A
  • MRAM N/A
  • EPS Growth
  • THRD N/A
  • MRAM N/A
  • EPS
  • THRD N/A
  • MRAM 0.04
  • Revenue
  • THRD N/A
  • MRAM $50,402,000.00
  • Revenue This Year
  • THRD N/A
  • MRAM $8.17
  • Revenue Next Year
  • THRD N/A
  • MRAM N/A
  • P/E Ratio
  • THRD N/A
  • MRAM $141.89
  • Revenue Growth
  • THRD N/A
  • MRAM N/A
  • 52 Week Low
  • THRD $3.18
  • MRAM $4.89
  • 52 Week High
  • THRD $16.94
  • MRAM $8.09
  • Technical
  • Relative Strength Index (RSI)
  • THRD 42.90
  • MRAM 34.38
  • Support Level
  • THRD $3.34
  • MRAM $5.10
  • Resistance Level
  • THRD $3.68
  • MRAM $5.29
  • Average True Range (ATR)
  • THRD 0.14
  • MRAM 0.14
  • MACD
  • THRD 0.07
  • MRAM 0.01
  • Stochastic Oscillator
  • THRD 62.86
  • MRAM 16.28

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).

Share on Social Networks: